The vaccine and biotherapeutic manufacturing industries are under pressure to address critical challenges of speed, scale, and supply in their response to SARS-CoV-2. What does this mean for technologies enabling production and how does this impact the future of vaccine and biotherapeutic manufacturing?
During this on-demand round table discussion, our panel of experts provide insights on challenges facing the industry and how they impact success. They speak to the future vision for vaccine and biotherapeutic manufacturing, and how Thermo Fisher Scientific can help to accelerate delivery in the battle against SARS-CoV-2.
Learning Objectives
- Industry challenges and how they impact success
- How to collaborate with suppliers to address critical challenges of speed, scale, and supply
Speaker Information
![Eric S. Langer](images/eric.jpg)
Eric S. Langer
Managing Partner
BioPlan Associates, Inc
![Christopher Murphy](images/christopher.jpg)
Christopher Murphy
Vice President/General Manager, Viral Vector Services/Pharma Services Group
Thermo Fisher Scientific
![Brandon Pence](images/brandon.jpg)
Brandon Pence
Vice President/General Manager, Purification and Pharma Analytics
Thermo Fisher Scientific
![Chris Williams](images/chris.jpg)
Chris Williams
Vice President/General Manager,
Single Use Technologies
Thermo Fisher Scientific
![Kate Torchilin](images/kate.jpg)
Kate Torchilin
Vice President/General Manager, Cell Culture and Cell Therapy
Thermo Fisher Scientific
Fill in the form to view the free on-demand webinar.